These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 6891473
1. Effects of desipramine on diurnal rhythms of plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) in depressed patients. DeMet EM, Halaris AE, Gwirtsman HE, Reno RM, Becker PI. Psychopharmacol Bull; 1982 Oct; 18(4):221-3. PubMed ID: 6891473 [No Abstract] [Full Text] [Related]
2. Apparent phase advance in diurnal MHPG rhythm in depression. Gwirtsman HE, Halaris AE, Wolf AW, DeMet E, Piletz JE, Marler M. Am J Psychiatry; 1989 Nov; 146(11):1427-33. PubMed ID: 2817113 [Abstract] [Full Text] [Related]
3. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression? Halbreich U, Sharpless N, Asnis GM, Endicott J, Goldstein S, Vital-Herne J, Eisenberg J, Zander K, Kang BJ, Shindledecker R. Arch Gen Psychiatry; 1987 Sep; 44(9):804-12. PubMed ID: 3632254 [Abstract] [Full Text] [Related]
4. The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions. Sack DA, James SP, Doran AR, Sherer MA, Linnoila M, Wehr TA. Arch Gen Psychiatry; 1988 Feb; 45(2):162-6. PubMed ID: 3337614 [Abstract] [Full Text] [Related]
5. Diurnal rhythm of plasma MHPG in endogenous depression. Halbreich U, Goldstein S, Sharpless N, Asnis G, Kang BJ, Ryan J. Psychiatry Res; 1987 Jan; 20(1):79-81. PubMed ID: 3562693 [No Abstract] [Full Text] [Related]
6. Plasma MHPG in depression: effects of acute and chronic desipramine treatment. Charney DS, Heninger GR, Sternberg DE, Roth RH. Psychiatry Res; 1981 Oct; 5(2):217-29. PubMed ID: 6945615 [Abstract] [Full Text] [Related]
7. Disruption of circadian MHPG rhythmicity in major depression. Piletz JE, DeMet E, Gwirtsman HE, Halaris A. Biol Psychiatry; 1994 Jun 01; 35(11):830-42. PubMed ID: 8054405 [Abstract] [Full Text] [Related]
8. MHPG circadian rhythmicity in blood of healthy subjects. Marler M, Halaris A, Piletz JE. Chronobiologia; 1990 Jun 01; 17(2):117-34. PubMed ID: 2394197 [Abstract] [Full Text] [Related]
9. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression. Wolkowitz OM, Doran AR, Breier A, Roy A, Jimerson DC, Sutton ME, Golden RN, Paul SM, Pickar D. Arch Gen Psychiatry; 1987 Sep 01; 44(9):782-9. PubMed ID: 3632251 [Abstract] [Full Text] [Related]
10. Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards. Veith RC, Bielski RJ, Bloom V, Fawcett JA, Narasimhachari N, Friedel RO. J Clin Psychopharmacol; 1983 Feb 01; 3(1):18-27. PubMed ID: 6833519 [Abstract] [Full Text] [Related]
11. Free 3-methoxy-4-hydroxyphenylglycol determined in plasma by liquid chromatography with coulometric detection. Hariharan M, VanNoord T, Cameron OG, Curtis GC, Ostrow DG. Clin Chem; 1989 Feb 01; 35(2):202-5. PubMed ID: 2914362 [Abstract] [Full Text] [Related]
12. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R, Siever LJ. J Psychiatr Res; 2004 Feb 01; 38(5):503-11. PubMed ID: 15380401 [Abstract] [Full Text] [Related]
13. Plasma MHPG and age at onset in depressed patients. Karege F, Bovier P, Gaillard JM, Tissot R. Psychiatry Res; 1989 Oct 01; 30(1):103-5. PubMed ID: 2594867 [No Abstract] [Full Text] [Related]
14. State dependence of noradrenergic activity in a rapidly cycling bipolar patient. Ostrow D, Halaris A, Dysken M, DeMet E, Harrow M, Davis J. J Clin Psychiatry; 1984 Jul 01; 45(7):306-9. PubMed ID: 6539774 [Abstract] [Full Text] [Related]
15. Increased plasma MHPG in dexamethasone-resistant depressed patients. Jimerson DC, Insel TR, Reus VI, Kopin IJ. Arch Gen Psychiatry; 1983 Feb 01; 40(2):173-6. PubMed ID: 6824413 [Abstract] [Full Text] [Related]
16. Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients. Trestman RL, Yehuda R, Coccaro E, Horvath T, Knott P, Gabriel S, Siever LJ. Biol Psychiatry; 1995 Apr 01; 37(7):448-56. PubMed ID: 7786958 [Abstract] [Full Text] [Related]
17. Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review. Yoshimura R, Nakamura J, Shinkai K, Ueda N. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul 01; 28(4):611-6. PubMed ID: 15276685 [Abstract] [Full Text] [Related]
18. Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol. Eisenhofer G, Goldstein DS, Ropchak TG, Nguyen HQ, Keiser HR, Kopin IJ. J Auton Nerv Syst; 1988 Sep 01; 24(1-2):1-14. PubMed ID: 3209794 [Abstract] [Full Text] [Related]
19. Noradrenergic function and the dexamethasone suppression test in depression. Morinobu S, Satoh H, Endoh M, Totsuka S. Jpn J Psychiatry Neurol; 1987 Dec 01; 41(4):669-76. PubMed ID: 3453415 [Abstract] [Full Text] [Related]
20. The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients. Karege F, Bovier P, Gaillard JM, Tissot R. Acta Psychiatr Scand; 1989 Nov 01; 80(5):499-504. PubMed ID: 2596350 [Abstract] [Full Text] [Related] Page: [Next] [New Search]